Page last updated: 2024-08-18

cyclohexanol and bupropion

cyclohexanol has been researched along with bupropion in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (22.62)	18.2507
2000's	35 (41.67)	29.6817
2010's	30 (35.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Preskorn, SH	1
Drevets, WC	1
Goodnick, PJ	1
Leonard, BE	1
Rothschild, AJ	1
Stoudemire, A	1
Benson, B; Danielson, A; Ketter, TA; Kimbrell, TA; Little, JT; Post, RM; Willis, MW	1
Stahl, SM	2
Spier, SA	1
Dogin, JW; Findling, RL	1
Hornig, M	1
Frye, MA; Ketter, TA; Little, JT; Luckenbaugh, D; Mathé, AA; Post, RM	1
Anand, VS; Dewan, MJ	1
Kirsch, MA; Louie, AK	1
Horst, WD; Preskorn, SH	1
Emamian, ES; Fatemi, SH; Kist, DA	1
Salzman, C	1
DeVane, CL; Pollock, BG	1
Bennett, VL; Bowen, RC; Chlan-Fourney, J; Juorio, AV; Li, XM; Shrikhande, S	1
Blass, DM; Pearson, VE	1
Abouesh, AI; Clayton, AH; McGarvey, EL; Pinkerton, RC	1
Conway, CR; Nelson, LA	1
Bagby, RM; Kennedy, SH; Vanderkooy, JD	1
Baker, GB; Kennedy, SH; Masellis, M; McCann, SM; McIntyre, RS; McKay, G; Raskin, J	1
Gupta, S; Masand, PS	1
Maidment, ID	1
DeVane, CL	1
Nemeroff, CB	1
Bannon, KM	1
Mitchell, PB	1
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM	1
Benson, BE; Dunn, RT; Ketter, TA; Kimbrell, TA; Little, JT; Luckenbaugh, DA; Post, RM; Willis, MW	1
Carey, TS; Gartlehner, G; Gaynes, BN; Hansen, RA; Lohr, KN; Randolph, LC	1
Almási, J; Rihmer, Z	1
Kennedy, SH; Lam, RW	1
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T	1
Millan, MJ	1
Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J	1
Clayton, AH; Haight, BR; Johnston, JA; Modell, JG; Thase, ME; Thompson, AH	1
Biggs, MM; Fava, M; Friedman, ES; Hollon, SD; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR	1
Gannon, RL; Millan, MJ	1
Fava, M; Papakostas, GI; Thase, ME	1
Chrzanowski, W; Gee, M; Hewett, K; Krishen, A; Leary, MO; Milanova, V; Millen, L; Modell, J; Savela, A; Schmitz, M	1
Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T	1
Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T	1
Hawley, P	1
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR	1
Fava, M; Gaynes, BN; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR	1
Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ	1
Evoniuk, G; Gee, MD; Hewett, K; Krishen, A; Le Clus, A; Modell, JG; Wunderlich, HP	1
Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE	1
Desmarais, JE; Looper, KJ	1
Howland, RH	1
Rush, AJ	1
Deuschle, M; Gilles, M; Paslakis, G	1
Katiyar, S; Kukade, G; Mahesh, R; Pandey, DK; Rudra, A; Viyogi, S	1
Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL	1
Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR	1
Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T	2
Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S	1
Hudson, AL; Lalies, MD; Silverstone, P	1
Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR	1
Bahk, WM; Jun, TY; Jung, YE; Song, HR; Wang, HR; Woo, YS	1
Nieoczym, D; Poleszak, E; Socała, K; Wlaź, P; Wyska, E	1
Chien, YL; Huang, E; Lin, YH	1
Fava, M; Perlis, RH; Perroud, N; Uher, R	1
Humpston, CS; Robinson, ES; Wood, CM	1
Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S	1
Andrade, C	1
Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR	1
Eurviriyanukul, K; Maneeton, B; Maneeton, N; Srisurapanont, M	1
Bijlsma, EY; Chan, JS; Millan, MJ; Olivier, B; Oosting, RS; Veening, JG; Waldinger, MD	1
Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S	1
Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P	1
Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR	1
Pieróg, M; Poleszak, E; Serefko, A; Szopa, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E	1

Reviews

26 review(s) available for cyclohexanol and bupropion

Article	Year
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6 Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1995
Geriatric depression: brain imaging correlates and pharmacologic considerations. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl A Topics: Age Factors; Aged; Antidepressive Agents; Brain; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Humans; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Models, Neurological; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride	1994
New approaches to the treatment of depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 4 Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride	1996
The diagnosis and treatment of late-life depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5 Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride	1996
New antidepressant drugs and the treatment of depression in the medically ill patient. The Psychiatric clinics of North America, 1996, Volume: 19, Issue:3 Topics: Adjustment Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Patient Care Team; Piperazines; Selective Serotonin Reuptake Inhibitors; Sick Role; Triazoles; Venlafaxine Hydrochloride	1996
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 4 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Dopamine; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Triazoles; Venlafaxine Hydrochloride	1998
Psychopharmacology of ADHD: children and adolescents. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7 Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1998
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Dopamine; Dopamine Antagonists; Epinephrine; Humans; Mental Disorders; Norepinephrine; Prevalence; Psychotropic Drugs; Serotonin; Venlafaxine Hydrochloride	1998
Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 18 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Drug Prescriptions; Humans; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	1998
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of affective disorders, 1998, Volume: 51, Issue:3 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Piperazines; Triazoles; Venlafaxine Hydrochloride	1998
Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Long-Term Care; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Pharmacokinetic considerations of antidepressant use in the elderly. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biotransformation; Bupropion; Creatinine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Half-Life; Humans; Intestinal Absorption; Liver; Male; Middle Aged; Piperazines; Triazoles; Venlafaxine Hydrochloride	1999
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2002, Volume: 14, Issue:3 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain	2002
The use of antidepressants to treat attention deficit hyperactivity disorder in adults. Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:3 Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Cyclohexanols; Humans; Propylamines; Venlafaxine Hydrochloride	2003
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 18 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Drug Tolerance; Half-Life; Humans; Nausea; Paroxetine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2003
Improving antidepressant adherence. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 18 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Health Promotion; Humans; Paroxetine; Patient Compliance; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2003
Therapeutic drug monitoring of non-tricyclic antidepressant drugs. Clinical chemistry and laboratory medicine, 2004, Volume: 42, Issue:11 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Mianserin; Piperazines; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride	2004
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. International clinical psychopharmacology, 2005, Volume: 20, Issue:2 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Outpatients; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Refusal; Venlafaxine Hydrochloride	2005
[Review of antidepressants from the TCAs to the third generation drugs]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:4 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride	2004
Using metaanalysis to evaluate evidence: practical tips and traps. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:3 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride	2005
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacology & therapeutics, 2006, Volume: 110, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dopamine; Dopamine Uptake Inhibitors; Drug Delivery Systems; Drug Design; Drug Therapy, Combination; Humans; Morpholines; Nerve Net; Neurons; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	2006
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biological psychiatry, 2008, Apr-01, Volume: 63, Issue:7 Topics: Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2008
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:12 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride	2009
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine. Drug design, development and therapy, 2013, Volume: 7 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride	2013
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacology, biochemistry, and behavior, 2014, Volume: 121 Topics: Animals; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Buspirone; Cyclohexanols; Disease Models, Animal; Dopamine; Female; Humans; Indoles; Male; Norepinephrine; Paroxetine; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior, Animal; Sexual Dysfunction, Physiological; Synaptic Transmission; Venlafaxine Hydrochloride	2014
Novel antidepressant drugs, arterial hypertension and cardiovascular disease. Recent patents on cardiovascular drug discovery, 2013, Volume: 8, Issue:3 Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013

Trials

28 trial(s) available for cyclohexanol and bupropion

Article	Year
Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacology bulletin, 1996, Volume: 32, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Tomography, Emission-Computed; Venlafaxine Hydrochloride	1996
Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biological psychiatry, 1999, Feb-01, Volume: 45, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain; Bupropion; Cross-Over Studies; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin; Venlafaxine Hydrochloride	1999
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Dopamine Uptake Inhibitors; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2002
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	2004
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biological psychiatry, 2005, Feb-01, Volume: 57, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Case-Control Studies; Cerebral Cortex; Cross-Over Studies; Cyclohexanols; Demography; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2005
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. The American journal of psychiatry, 2006, Volume: 163, Issue:2 Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2006
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride	2006
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. The British journal of psychiatry : the journal of mental science, 2006, Volume: 189 Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2006
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Patient Compliance; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	2006
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STARD report. The American journal of psychiatry, 2007, Volume: 164, Issue:5* Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride	2007
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Venlafaxine Hydrochloride	2009
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of general psychiatry, 2008, Volume: 65, Issue:8 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride	2008
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4 Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2009
What did STARD teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adolescent; Adult; Aged; Bupropion; Citalopram; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Primidone; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Pharmacogenetics studies in STARD: strengths, limitations, and results. Psychiatric services (Washington, D.C.), 2009, Volume: 60, Issue:11* Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2009
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:8 Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2010
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride	2010
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. The American journal of psychiatry, 2011, Volume: 168, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Personality Inventory; Recurrence; Selective Serotonin Reuptake Inhibitors; Self Report; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. Journal of affective disorders, 2011, Volume: 133, Issue:3 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride	2011
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2012, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2012
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of clinical psychiatry, 2011, Volume: 72, Issue:10 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2011
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1* Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult	2012
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depression and anxiety, 2012, Volume: 29, Issue:2 Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychological medicine, 2013, Volume: 43, Issue:5 Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. The American journal of psychiatry, 2013, Volume: 170, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult	2013
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care. Journal of psychiatric practice, 2014, Volume: 20, Issue:2 Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride	2014
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. Journal of affective disorders, 2015, Mar-15, Volume: 174 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride	2015

Other Studies

30 other study(ies) available for cyclohexanol and bupropion

Article	Year
Treatment of chronic fatigue syndrome with venlafaxine. The American journal of psychiatry, 1996, Volume: 153, Issue:2 Topics: Adult; Bupropion; Cyclohexanols; Fatigue Syndrome, Chronic; Female; Humans; Killer Cells, Natural; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1996
Use of bupropion with SRIs and venlafaxine. Depression and anxiety, 1998, Volume: 7, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1998
Evaluating the tolerability of the newer antidepressants. The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2 Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride	1999
Combination treatment with venlafaxine and bupropion. The American journal of psychiatry, 1999, Volume: 156, Issue:3 Topics: Adult; Bupropion; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride	1999
Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1). Journal of psychiatry & neuroscience : JPN, 2000, Volume: 25, Issue:1 Topics: Amitriptyline; Animals; Antidepressive Agents; Bupropion; Cyclohexanols; Dose-Response Relationship, Drug; Doxepin; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Neurons; PC12 Cells; Rats; RNA, Messenger; Superoxide Dismutase; Tumor Cells, Cultured; Up-Regulation; Venlafaxine Hydrochloride	2000
SIADH with multiple antidepressants in a geriatric patient. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6 Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2000
Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2001
The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity. The journal of ECT, 2001, Volume: 17, Issue:3 Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bupropion; Cyclohexanols; Electroconvulsive Therapy; Humans; Lithium Carbonate; Male; Middle Aged; Seizures; Time Factors; Venlafaxine Hydrochloride	2001
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:2 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2002
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety. Consumer reports, 2004, Volume: 69, Issue:10 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work	2004
Clarification to SSRI table. Advance for nurse practitioners, 2004, Volume: 12, Issue:11 Topics: Bupropion; Cyclohexanols; Dopamine Uptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Venlafaxine Hydrochloride	2004
Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms. Psychopharmacology, 2007, Volume: 195, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Bupropion; Circadian Rhythm; Cricetinae; Cyclohexanols; Dopamine Uptake Inhibitors; Light; Male; Mesocricetus; Morpholines; Motor Activity; Reboxetine; Running; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2007
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. The American journal of psychiatry, 2009, Volume: 166, Issue:2 Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult	2009
Nontricyclic antidepressants for neuropathic pain #187. Journal of palliative medicine, 2009, Volume: 12, Issue:5 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Duloxetine Hydrochloride; Humans; Neuralgia; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride	2009
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
When is a "generic" medication not really a generic? Journal of psychosocial nursing and mental health services, 2010, Volume: 48, Issue:2 Topics: Bupropion; Cyclohexanols; Drug Costs; Drug Labeling; Drug Prescriptions; Drugs, Generic; Humans; Marketing of Health Services; Paroxetine; Patient Selection; Psychiatric Nursing; Psychotropic Drugs; Therapeutic Equivalency; United States; United States Food and Drug Administration; Valproic Acid; Venlafaxine Hydrochloride	2010
Combining antidepressant medications: a good idea? The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2010
Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2010
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian journal of experimental biology, 2010, Volume: 48, Issue:5 Topics: Acceleration; Amitriptyline; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain Injuries; Bupropion; Citalopram; Cyclohexanols; Exploratory Behavior; Fear; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Social Behavior; Venlafaxine Hydrochloride	2010
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. Aquatic toxicology (Amsterdam, Netherlands), 2011, Volume: 104, Issue:1-2 Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical	2011
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? Depression and anxiety, 2011, Volume: 28, Issue:11 Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride	2011
Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:6 Topics: Animals; Antidepressive Agents; Bupropion; Cyclohexanols; Dopamine; Extracellular Space; Frontal Lobe; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Venlafaxine Hydrochloride	2012
Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Platelet Count; Retrospective Studies; Venlafaxine Hydrochloride	2012
Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice. Pharmacology, biochemistry, and behavior, 2012, Volume: 103, Issue:2 Topics: Animals; Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Cyclohexanols; Locomotion; Male; Mice; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swimming; Venlafaxine Hydrochloride	2012
Bilateral pallidal necrosis and cardiac toxicity in a patient with venlafaxine and bupropion overdose. The American journal of psychiatry, 2012, Volume: 169, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Overdose; Female; Globus Pallidus; Heart; Humans; Magnetic Resonance Imaging; Necrosis; Venlafaxine Hydrochloride	2012
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride	2012
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task. Journal of psychopharmacology (Oxford, England), 2013, Volume: 27, Issue:2 Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2013
Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:2 Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Risk Factors; Treatment Failure; Venlafaxine Hydrochloride	2013
The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life sciences, 2015, Sep-01, Volume: 136 Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Caffeine; Cyclohexanols; Cyclopropanes; Drug Evaluation, Preclinical; Drug Interactions; Male; Mice; Milnacipran; Moclobemide; Motor Activity; Swimming; Venlafaxine Hydrochloride	2015